1. Home
  2. HDSN vs QTTB Comparison

HDSN vs QTTB Comparison

Compare HDSN & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hudson Technologies Inc.

HDSN

Hudson Technologies Inc.

N/A

Current Price

$4.33

Market Cap

252.0M

ML Signal

N/A

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

N/A

Current Price

$8.79

Market Cap

265.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HDSN
QTTB
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
252.0M
265.2M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
HDSN
QTTB
Price
$4.33
$8.79
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$6.44
★ $39.67
AVG Volume (30 Days)
546.4K
★ 551.6K
Earning Date
10-28-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 136.78
EPS
★ 0.12
N/A
Revenue
★ $237,118,000.00
$53,737,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.68
$150.00
P/E Ratio
$35.25
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.10
$1.91
52 Week High
$8.79
$23.57

Technical Indicators

Market Signals
Indicator
HDSN
QTTB
Relative Strength Index (RSI) 26.24 49.67
Support Level N/A $7.45
Resistance Level $6.47 $9.16
Average True Range (ATR) 0.18 0.49
MACD -0.11 0.22
Stochastic Oscillator 14.82 82.65

Price Performance

Historical Comparison
HDSN
QTTB

About HDSN Hudson Technologies Inc.

Hudson Technologies Inc is a refrigerant services company providing solutions to recurring challenges within the refrigeration industry. The company delivers environmentally sustainable offerings, covering the sale of refrigerant gases, recovery, reclamation, and reuse, as well as improving equipment performance through energy efficiency services, emergency air conditioning and refrigeration system repairs, refrigerant disposal, and carbon credit trading. It operates through one reportable segment. Its products and services are used in commercial air conditioning, industrial processing, and refrigeration systems, and include refrigerant and industrial gas sales, refrigerant management services (mainly reclamation of refrigerants), and RefrigerantSide services performed at customer sites.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

Share on Social Networks: